Compare RGS & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGS | MDCX |
|---|---|---|
| Founded | 1922 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 53.4M |
| IPO Year | 1991 | N/A |
| Metric | RGS | MDCX |
|---|---|---|
| Price | $25.84 | $1.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 5.7K | ★ 305.0K |
| Earning Date | 02-11-2026 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.05 | N/A |
| EPS | ★ 45.08 | N/A |
| Revenue | ★ $223,032,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.58 | ★ N/A |
| Revenue Growth | ★ 13.98 | N/A |
| 52 Week Low | $15.00 | $1.45 |
| 52 Week High | $31.50 | $8.94 |
| Indicator | RGS | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 35.83 | 40.00 |
| Support Level | $24.98 | $1.45 |
| Resistance Level | $27.75 | $1.70 |
| Average True Range (ATR) | 0.77 | 0.13 |
| MACD | -0.31 | 0.02 |
| Stochastic Oscillator | 11.66 | 43.02 |
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.